https://radboudtranslationalmedicine.nl/en/news/rtm-supports-citrylls-imaging-trial-of-89zrzr-dfo-cit-013https://radboudtranslationalmedicine.nl/en/news/linkedin-post-isologic-goes-electrichttps://radboudtranslationalmedicine.nl/en/products/radelumin-18f-psma-1007https://radboudtranslationalmedicine.nl/en/about-us/stijn-bekkerhttps://radboudtranslationalmedicine.nl/en/about-us/chinouk-klaassen-heijmanshttps://radboudtranslationalmedicine.nl/en/products/neuraceq-18f-florbetabenhttps://radboudtranslationalmedicine.nl/en/about-us/chang-guohttps://radboudtranslationalmedicine.nl/en/news/rtm-added-as-distributor-neuraceqhttps://radboudtranslationalmedicine.nl/en/news/first-patient-dosed-with-tlx250-cdx-in-italy-for-ccrcchttps://radboudtranslationalmedicine.nl/en/news/linkedin-post-esrr2024https://radboudtranslationalmedicine.nl/en/news/abx-has-received-marketing-authorisation-for-the-radiotracer-radelumin-in-germanyhttps://radboudtranslationalmedicine.nl/en/products/radio-flu-18f-naf-2https://radboudtranslationalmedicine.nl/en/news/first-patient-dosed-in-phase-ii-study-of-tlx250-cdx-in-triple-negative-breast-cancer-3https://radboudtranslationalmedicine.nl/en/about-us/ginny-van-der-sluyshttps://radboudtranslationalmedicine.nl/en/about-us/kristell-chatalichttps://radboudtranslationalmedicine.nl/en/about-us/marielle-kerstenhttps://radboudtranslationalmedicine.nl/en/news/huntingtons-disease-a-review-of-the-known-pet-imaging-biomarkers-and-targeting-radiotracershttps://radboudtranslationalmedicine.nl/en/about-us/anne-van-de-beekhttps://radboudtranslationalmedicine.nl/en/news/cooperation-rtm-alliance-medicalhttps://radboudtranslationalmedicine.nl/en/news/rtm-receives-marketing-authorisation-for-fludeoxyglucose-18fhttps://radboudtranslationalmedicine.nl/en/news/1st-production-quiremsphereshttps://radboudtranslationalmedicine.nl/en/news/production-of-novel-diagnostic-radionuclides-in-small-medical-cyclotronshttps://radboudtranslationalmedicine.nl/en/cookie-statementhttps://radboudtranslationalmedicine.nl/en/news/first-liver-cancer-patient-treated-with-microspheres-irradiated-in-tu-delfthttps://radboudtranslationalmedicine.nl/en/collaborationshttps://radboudtranslationalmedicine.nl/en/news/18f-fdopa-now-availablehttps://radboudtranslationalmedicine.nl/en/jobshttps://radboudtranslationalmedicine.nl/en/news/gmp-certificate-receivedhttps://radboudtranslationalmedicine.nl/en/news/gmp-certificate-received-2https://radboudtranslationalmedicine.nl/en/news/upcoming-eventhttps://radboudtranslationalmedicine.nl/en/disclaimerhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/whats-in-it-for-the-patienthttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/is-such-a-major-investment-justifiable-in-this-time-of-cost-containment-and-budget-constraintshttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/why-the-name-translational-medicinehttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/does-the-cyclotron-yield-any-radioactive-wastehttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/what-are-the-costs-associated-with-the-construction-of-this-facilityhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/how-much-radioactive-material-will-be-produced-by-the-cyclotronhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/is-the-radioactive-material-administered-for-a-pet-scan-harmfulhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/why-has-this-cyclotron-facility-been-constructedhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/what-are-the-risks-of-a-cyclotron-facilityhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/are-the-radioactive-materials-produced-dangeroushttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/what-is-a-pet-scanhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/how-much-radiation-is-a-patient-exposed-to-during-a-pet-scanhttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/can-there-be-a-melt-down-in-a-cyclotron-with-all-negative-consequenceshttps://radboudtranslationalmedicine.nl/en/frequently-asked-questions/what-is-a-cyclotronhttps://radboudtranslationalmedicine.nl/en/products/11c-tracershttps://radboudtranslationalmedicine.nl/en/products/18f-fdghttps://radboudtranslationalmedicine.nl/en/researchhttps://radboudtranslationalmedicine.nl/en/contacthttps://radboudtranslationalmedicine.nl/en/general-conditionshttps://radboudtranslationalmedicine.nl/en/frequently-asked-questionshttps://radboudtranslationalmedicine.nl/en/about-ushttps://radboudtranslationalmedicine.nl/en/about-us/vera-bloemershttps://radboudtranslationalmedicine.nl/en/about-us/lars-perkhttps://radboudtranslationalmedicine.nl/en/about-us/mateusz-synowieckihttps://radboudtranslationalmedicine.nl/en/productshttps://radboudtranslationalmedicine.nl/enhttps://radboudtranslationalmedicine.nl/en/news